Haleon (HLN) Other Non-Current Liabilities (2021 - 2025)

Haleon (HLN) posted Other Non-Current Liabilities of $39.9 million for Q4 2025, up 11.04% on a QoQ basis from $35.9 million in Q4 2024, and up 11.04% year-over-year from $35.9 million in Q4 2024.

Haleon (HLN) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

Haleon's Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $39.9 million for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 11.04% year-over-year to $39.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $39.9 million (up 11.04% YoY) and the FY2025 annual result came in at $39.6 million, up 10.52% from the prior year.
  • Other Non-Current Liabilities was $39.9 million for Q4 2025 at Haleon, up from $35.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $48.4 million in Q4 2023 and bottomed at -$34.1 million in Q2 2024.
  • A 5-year average of $11.5 million and a median of $18.3 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 139.28% — and 2023, when it tumbled 264.35%.
  • Haleon's Other Non-Current Liabilities stood at $10.8 million in 2021, then surged by 139.28% to $25.8 million in 2022, then surged by 87.58% to $48.4 million in 2023, then dropped by 25.76% to $35.9 million in 2024, then rose by 11.04% to $39.9 million in 2025.
  • Business Quant data shows HLN's Other Non-Current Liabilities at $39.9 million in Q4 2025, $35.9 million in Q4 2024, and -$34.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 39.90 Mn
Dec 31, 2024 35.94 Mn
Jun 30, 2024 -34.08 Mn
Dec 31, 2023 48.40 Mn
Jun 30, 2023 -27.53 Mn
Dec 31, 2022 25.80 Mn
Jun 30, 2022 -7.56 Mn
Dec 31, 2021 10.78 Mn